Lessons for Lassa

The interests of pregnant women must be addressed in the fight against Lassa fever, urge a trio of bioethicists.
The global health community should draw lessons from the Ebola response in the Democratic Republic of Congo, where the only available Ebola vaccine is problematic for use during pregnancy. As a result, pregnant women are not being given the option of vaccination, explain the authors from Johns Hopkins Vaccine Initiative and the Center for Global Development. A Lassa fever vaccine to offer pregnant women would be an important double win for global health, they say—protecting pregnant women and their infants, and providing a model for future development of vaccines for use in epidemics.
Tomorrow, they note, the first international conference on Lassa fever will be held in Nigeria—an ideal opportunity to highlight steps needed to avoid the same problems in future Lassa fever outbreaks.

Secondary Topic
Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top